CTNM
Contineum Therapeutics, Inc. Class A Common StockNASDAQHealthcare$13.44+0.00%ClosedMarket Cap: $501.8M
As of 2026-04-06
Insider Statistics (Q2 2026)
Purchases
0
Sales
1
Buy/Sell Ratio
0.00
Total Bought
$0.00
Total Sold
$1.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Mon Apr 06 | Lorrain Daniel S. | officer: Chief Scientific Officer | Sell | 4,170 | $13.43 | 147,712 |
| Mon Mar 02 | Watkins Tim | officer: CMO & Head of Development | Sell | 3,611 | $4.50 | 249,167 |
| Mon Mar 02 | Watkins Tim | officer: CMO & Head of Development | Sell | 3,611 | $15.02 | 0 |
| Mon Mar 02 | Lorrain Daniel S. | officer: Chief Scientific Officer | Sell | 4,170 | $15.01 | 151,882 |
| Thu Feb 26 | Stengone Carmine N. | director, officer: CEO and President | Sell | 2,700 | $1.26 | 120,917 |
| Thu Feb 26 | Stengone Carmine N. | director, officer: CEO and President | Sell | 4,400 | $16.02 | 14,954 |
| Thu Feb 26 | Stengone Carmine N. | director, officer: CEO and President | Sell | 2,700 | $16.02 | 14,954 |
| Thu Feb 26 | Stengone Carmine N. | director, officer: CEO and President | Sell | 4,400 | $1.26 | 123,617 |